Differential Expression of Pancreatic Protein and Chemosensing Receptor mRNAs in NKCC1-null Intestine by Bradford, Emily M. et al.
University of Kentucky
UKnowledge
Internal Medicine Faculty Publications Internal Medicine
2-15-2016
Differential Expression of Pancreatic Protein and
Chemosensing Receptor mRNAs in NKCC1-null
Intestine
Emily M. Bradford
University of Kentucky, emily.bradford@uky.edu
Kanimozhi Vairamani
University of Cincinnati
Gary E. Shull
University of Cincinnati
Right click to open a feedback form in a new tab to let us know how this document benefits you.
Follow this and additional works at: https://uknowledge.uky.edu/internalmedicine_facpub
Part of the Gastroenterology Commons
This Article is brought to you for free and open access by the Internal Medicine at UKnowledge. It has been accepted for inclusion in Internal Medicine
Faculty Publications by an authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.
Repository Citation
Bradford, Emily M.; Vairamani, Kanimozhi; and Shull, Gary E., "Differential Expression of Pancreatic Protein and Chemosensing
Receptor mRNAs in NKCC1-null Intestine" (2016). Internal Medicine Faculty Publications. 86.
https://uknowledge.uky.edu/internalmedicine_facpub/86
Differential Expression of Pancreatic Protein and Chemosensing Receptor mRNAs in NKCC1-null Intestine
Notes/Citation Information
Published in World Journal of Gastrointestinal Pathophysiology, v. 7, issue 1, p. 138-149.
© 2016 Baishideng Publishing Group Inc. All rights reserved.
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by
external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial
(CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-
commercially, and license their derivative works on different terms, provided the original work is properly
cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Digital Object Identifier (DOI)
https://doi.org/10.4291/wjgp.v7.i1.138
This article is available at UKnowledge: https://uknowledge.uky.edu/internalmedicine_facpub/86
Differential expression of pancreatic protein and 
chemosensing receptor mRNAs in NKCC1-null intestine
Emily M Bradford, Kanimozhi Vairamani, Gary E Shull
Emily M Bradford, Department of Internal Medicine, Division 
of Gastroenterology, University of Kentucky, Lexington, KY 
40536-0298, United States
Kanimozhi Vairamani, Gary E Shull, Department of Molecular 
Genetics, Biochemistry and Microbiology, University of Cincinnati 
College of Medicine, Cincinnati, OH 45267-0524, United States
Author contributions: Bradford EM and Shull GE conceived the 
study, analyzed the data, and wrote the manuscript; Vairamani K 
analyzed and compiled microarray data; Bradford EM performed 
all of the experiments.
Supported by National Institutes of Health to Gary E Shull, No. 
DK050594.
Institutional review board statement: Because human 
subjects or tissues were not used in this study, approval from 
the institutional review board was not required. Ethical issues 
relating to the animal protocol were reviewed and approved by the 
Institutional Animal Care and Use Committee of the University of 
Cincinnati. 
Institutional animal care and use committee statement: All 
procedures involving animals were reviewed and approved by the 
Institutional Animal Care and Use Committee (IACUC) of the 
University of Cincinnati (protocol number: 06-06-22-02).
Conflict-of-interest statement: The authors have no conflict of 
interest related to this manuscript.
Data sharing statement: The microarray data have been 
deposited in the National Center for Biotechnology Gene 
Expression Omnibus and can be freely accessed as described in 
Methods. The Slc12a2 (NKCC1) knockout mouse model has 
been deposited in a publically available repository and can be 
accessed as described in Methods.
Open-Access: This article is an open-access article which was 
selected by an in-house editor and fully peer-reviewed by external 
reviewers. It is distributed in accordance with the Creative 
Commons Attribution Non Commercial (CC BY-NC 4.0) license, 
which permits others to distribute, remix, adapt, build upon this 
work non-commercially, and license their derivative works on 
different terms, provided the original work is properly cited and 
the use is non-commercial. See: http://creativecommons.org/
licenses/by-nc/4.0/
Correspondence to: Gary E Shull, PhD, Professor, Department 
of Molecular Genetics, Biochemistry and Microbiology, Univer-
sity of Cincinnati College of Medicine, 231 Albert Sabin Way, 
Cincinnati, OH 45267-0524, 
United States. shullge@ucmail.uc.edu
Telephone: +1-513-5580056
Fax: +1-513-5591885
Received: June 29, 2015 
Peer-review started: July 2, 2015 
First decision: September 22, 2015
Revised: October 10, 2015 
Accepted: December 17, 2015 
Article in press: December 18, 2015
Published online: February 15, 2016
Abstract
AIM: To investigate the intestinal functions of the NKCC1 
Na+-K+-2Cl cotransporter (SLC12a2  gene), differential 
mRNA expression changes in NKCC1-null intestine were 
analyzed.
METHODS: Microarray analysis of mRNA from intestines 
of adult wild-type mice and gene-targeted NKCC1-
null mice (n = 6 of each genotype) was performed to 
identify patterns of differential gene expression changes. 
Differential expression patterns were further examined 
by Gene Ontology analysis using the online Gorilla 
program, and expression changes of selected genes were 
verified using northern blot analysis and quantitative 
real time-polymerase chain reaction. Histological staining 
and immunofluorescence were performed to identify cell 
types in which upregulated pancreatic digestive enzymes 
were expressed. 
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Basic Study
ORIGINAL ARTICLE
RESULTS: Genes typically associated with pancreatic 
function were upregulated. These included lipase, 
amylase, elastase, and serine proteases indicative of 
pancreatic exocrine function, as well as insulin and 
regenerating islet genes, representative of endocrine 
function. Northern blot analysis and immunohistoche-
mistry showed that differential expression of exocrine 
pancreas mRNAs was specific to the duodenum and 
localized to a subset of goblet cells. In addition, a major 
pattern of changes involving differential expression of 
olfactory receptors that function in chemical sensing, as 
well as other chemosensing G-protein coupled receptors, 
was observed. These changes in chemosensory receptor 
expression may be related to the failure of intestinal 
function and dependency on parenteral nutrition 
observed in humans with SLC12a2  mutations. 
CONCLUSION: The results suggest that loss of NKCC1 
affects not only secretion, but also goblet cell function 
and chemosensing of intestinal contents via  G-protein 
coupled chemosensory receptors.
Key words: SLC12a2 ; Chemosensory; Chemosensitivity; 
Gastrointestinal; Dyspepsia 
© The Author(s) 2016. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: The NKCC1 Na+-K+-2Cl- cotransporter is a 
major mechanism of Cl- uptake in support of secretion. 
To investigate its intestinal functions we analyzed mRNA 
expression changes in NKCC1-null intestines. Differ-
entially expressed genes included digestive enzymes 
and a large number of olfactory and other G-protein 
coupled receptors that function in chemical sensing. This 
suggests that loss of NKCC1 affects not only secretion, 
but also digestion and chemosensing of components 
of the intestinal contents. The results likely have relev-
ance to recent evidence showing that mutations in the 
human NKCC1 gene cause unexplained food intolerance 
and failure of intestinal function requiring parenteral 
nutrition.
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INTRODUCTION
The NKCC1 Na+-K+-2Cl- cotransporter, encoded by the 
SLC12A2 gene, is expressed in all mammalian tissues 
and is particularly prominent in epithelial cells of the 
gastrointestinal tract[1]. Detailed immunohistoche-
mical studies show that it is localized to basolateral 
membranes of intestinal secretory epithelia[1], where it 
mediates uptake of much of the Cl- that is then secreted 
through the apical cystic fibrosis transmembrane con­
ductance regulator (CFTR). In addition to secretory 
epithelia, NKCC1 is expressed in all segments of the 
gastrointestinal tract and throughout the crypt and 
villus epithelium, including both absorptive cells and 
goblet cells[1]. Thus, loss or inhibition of NKCC1 could 
have wide-ranging effects on gastrointestinal function. 
In fact, a National Institutes of Health web site (http://
www.genome.gov/27551936) on Rare or Undiagnosed 
Diseases reports that humans with SLC12A2 mutations 
have “exercise intolerance, dilated cardiomyopathy, 
and episodic hypoglycemia progressing to unexplained 
failure of intestinal function/food tolerance with sub-
sequent parenteral nutrition dependency”. The basis 
for the severe intestinal phenotype in humans is not 
known, but since it does not mimic the Cystic Fibrosis 
intestinal phenotype, it is unlikely to be due entirely to 
the secretory defect. 
When anion secretion is impaired, the intestinal 
lumen can become desiccated, which leads to consti-
pation, obstructions, and intussusception. Mice lacking 
CFTR usually develop lethal intestinal obstructions 
by 6 wk of age and require treatment with an osmo-
tic laxative for normal survival[2], but the intestinal 
phenotype of Nkcc1-/- mice is much less severe[3]. In the 
original study, a small percentage of the Nkcc1-/- mice 
on a mixed genetic background developed intestinal 
impactions[3]. However, Nkcc1-/- mice on the FVB/N 
background (Swiss mice carrying the Fv1b sensitizing 
allele) that were used for the current study do not 
develop impactions, and the intestinal tract appears 
histologically normal.
Loss of NKCC1 in mice causes a defect in intestinal 
anion secretion as measured by reductions in the 
bumetanide-sensitive component in short circuit currents 
in duodenum, jejunum, and cecum[3-5]. However, com-
pensatory pathways for basolateral Cl- uptake have 
been identified in duodenum and colon[5,6], providing an 
explanation of why the loss of NKCC1 does not cause a 
profound defect in anion secretion in the intestinal tract. 
To gain a better understanding of the functions of NKCC1 
and the molecular consequences of NKCC1-deficiency 
in the intestine, we performed microarray analyses 
of mRNA from Nkcc1-/- small intestine. The observed 
alterations in the expression of mRNAs encoding 
digestive enzymes and receptors that mediate chemical 
sensing could be involved in intestinal pathologies 
resulting from the inhibition or loss of NKCC1.
MATERIALS AND METHODS
NKCC1-null mutant mouse model 
Nkcc1-/- mice were generated as previously described[3] 
and inbred onto the FVB/N background for at least 10 
generations. FVB/N are Swiss mice, derived from the 
HFSF/N strain, which carry the Fv1b (Friend Leukemia 
Virus strain B) sensitizing allele. These Nkcc1-/- mice are 
available from the Jackson Labs Mutant Mouse Regional 
Resource Center and can be identified by searching 
Bradford EM et al . Expression changes in NKCC1-null intestine
139 February 15, 2016|Volume 7|Issue 1|WJGP|www.wjgnet.com
(http://www.jax.org/mmrrc/) with the gene symbol 
Slc12a2 (strain name: FVB.Cg-Slc12a2tm1Ges). Wild-
type (WT) FVB/N mice were originally obtained from 
Jackson Labs and bred in house. All experimental pairs 
were derived by breeding of NKCC1 heterozygous 
breeding pairs, were between 8 and 12 wk of age, 
and were age- and gender-matched. Mouse numbers 
(n) are indicated in methods or figure legends. Mice 
were maintained in a specific pathogen-free barrier 
facility, with access to food and water ad libitum, and 
all experiments were approved by the University of 
Cincinnati Animal Care and Use Committee.
Isolation of intestinal tissues
Mice were anesthetized by intraperitoneal injection 
of Avertin (2.5% solution of Tribromethanol) at 500 
mg/kg, followed by cervical dislocation after the mice 
were anesthetized. Intestinal segments were removed 
and flushed with ice-cold phosphate-buffered saline. 
Some samples were frozen in liquid nitrogen and used 
for extraction of total RNA using Tri-Reagent (Molecular 
Research Center) and others were processed for 
immunolocalization studies as described in detail below.
Northern blot analysis and real-time polymerase chain 
reaction
Northern blot analysis was performed using 10 mg of 
total RNA per sample, and blots were hybridized with 
32P-labeled cDNA as previously described[7]. Primer 
sequences are given in Table 1. Quantification of 
band intensity, including background subtraction and 
normalization to the ribosomal L32 subunit mRNA, 
was done using ImageQuant software (Amersham 
Biosciences).
For quantitative real-time polymerase chain reaction 
(PCR), 4 μg of total RNA was reversed transcribed using 
oligo d(T) and SuperScript Ⅱ reverse transcriptase 
(Invitrogen). The cDNA was diluted 5-fold in water. 
Primer sequences are given in Table 1. For each primer 
set, optimization using serially-diluted standards and 
melting curve analysis was performed. Real-time PCR 
was run on a DNA Engine Opticon Ⅱ (MJ Research) 
thermalcycler using iQ SYBR Green (BioRad). For each 
gene, samples were run at least in duplicate, and 
mean values were normalized to the expression of 
L32. Standard curves were prepared for each gene on 
every run. All pairwise comparisons were done using 
a student’s t-test; P-values of < 0.05 were considered 
significant.
Morphology and immunofluorescence
Intestinal segments were fixed in 10% neutral buffered 
formalin overnight and embedded in paraffin. Goblet 
cells were identified with hemotoxylin and eosin (H and 
E) or Alcian Blue/Periodic Acid-Schiff (AB/PAS) staining 
as described previously[8]. For immunofluorescence, 
sections (n = 4 WT and 3 NKCC1-null mutant) were 
deparaffinized in Citrisolve, rehydrated through succe­
ssive ethanol washes, and boiled for 5 min in a sodium 
citrate buffer. Sections were incubated with primary 
antibodies for 12 h at room temperature, washed, 
and incubated with either another primary antibody 
or the appropriate secondary antibodies for 12 h 
at room temperature. Polyclonal antibodies against 
amylase (Sigma), trypsin (Abcam), elastase (Abcam), 
and intestinal trefoil factor 3 (TFF3) (ITF-Santa Cruz 
Biotechnology) were used at a 1:100 dilution; all 
secondary antibodies (Alexa Fluor, Molecular Probes) 
were used at a 1:200 dilution, and DAPI was included in 
the mounting medium (Vector Laboratories) for staining 
of nuclei. For localization studies using both fluorescence 
and AB/PAS, immunohistochemistry was done first and 
the slides were photographed. The slides were then 
washed, AB/PAS staining was performed, and the same 
areas were imaged. For colocalization studies, images 
were merged in Adobe Photoshop.
Microarray analysis
Microarray analyses were performed by the University 
of Cincinnati Genomics and Microarray Laboratory core 
facility exactly as described previously[8] using the Duke 
University Murine Operon v.3.0 spotted Array, which 
consisted of the Operon mouse oligonucleotide library, 
version 3.0, comprised of 70-mer oligonucleotides 
representing mouse genes. For analysis of NKCC1-null 
small intestine, total RNA was isolated from the entire 
small intestine of 8-wk old WT and NKCC1-null mutant 
(KO) mice (n = 6 of each genotype) on the FVB/N 
background, and cDNA was generated and labeled 
with Cy3 or Cy5 fluorophores and hybridized with the 
microarrays. The fold­changes and statistical significance 
for the microarray analysis were calculated exactly as 
described previously[8]. Briefly, Cy3 and Cy5 labeling 
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Name Sequence
Pdx1 F: ACCAAAGCTCACGCGTGGAAA
R: TGATGTGTCTCTCGGTCAAGTT
Insulin 1 F: TTGCCCTCTGGGAGCCCAAA
R: CAGATGCTGGTGCAGCACTG
Insulin 2 F: TCTTCCTCTGGGAGTCCCAC
R: CAGATGCTGGTGCAGCACTG
Glut2 F: CATTGCTGGAAGAAGCGTATCAG
R: GAGACCTTCTGCTCAGTCGACG
Amylase F: TTAACGATAATAAATGTAATGGAGAA
R: CCCTGCTACTCCAATGTCAA
Trypsin F: TGAGCAGTTTGTCAATTCTGCC
R: GCATGATGTCGTTGTTCAGGG
Elastase F: GTAGTTGCAGCCCAGAGAGG
R: TCTGCTATGTCACAGGCTGG
Gp2 F: TCCCTGCCAGAATCACACGGT
R: GGAGGTCCTGCCTACAGACACA
L32 F: GATCTAGCGGCCGCCATCTGTTTACGGCATCATG
R: TAGATCGCGGCCGCCGCTCCCATAACCGATGTTGG
Table 1  Primer sequences used for quantitative real-time 
polymerase chain reaction and northern blot analyses
Forward and reverse primers for quantitative real-time polymerase chain 
reaction and northern blot probes are listed 5’ to 3’.
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genes exhibiting differential expression in the Nkcc1-null 
intestine, all were upregulated, with induction ranging 
from 3.5-fold to 15.8-fold (Table 2). A pattern of 
genes typically associated with the exocrine pancreas, 
namely the digestive enzymes and components of the 
zymogen granules, was immediately apparent. Cpa1 
is a pancreatic carboxypeptidase that was upregulated 
15.8-fold. Elastases 1, 2, and 3B were all up-regulated 
and exhibited high fluorescence intensities. Several 
serine proteases, including trypsins 1, 2, 4, and 10, as 
well as chymotrypsins A, B and C, were also up-regu-
lated. Amylase, another digestive enzyme produced by 
the pancreas, was increased 8.7-fold. Besides digestive 
enzymes, a number of the highly upregulated genes 
encode proteins that are associated with zymogen 
granules (see Discussion). These included glycoprotein 
2 (Gp2, 3.9­fold), pancreatic protein disulfide isomerase 
(Pdia2, 4.5-fold), and syncollin (Sycn, 3.0-fold; P < 
0.001, data not shown). 
In addition to enzymes typical of the exocrine pan-
creas, genes commonly expressed in the endocrine 
pancreas were also upregulated. These included Reg1 
and Reg2 (regenerating islet or pancreatic stone 
proteins)[10], which were upregulated 4.6- and 3.6-fold 
(Table 2), insulin 1 (Ins1, 1.92-fold; P < 0.003), and 
pancreatic-duodenal homeobox 1 (Pdx1; 2.53-fold, 
P < 0.002), which is heavily involved in regulation of 
β-cell function[11]. Glut2, which is the most abundant 
facilitative glucose transporter in the intestine[12], was 
also upregulated (1.65-fold, P < 0.007).
Northern blot analysis and quantitative RT-PCR of 
several genes validated the results of the microarray 
analysis (Figure 1). The expression of elastase (4.7-fold), 
amylase (1.9-fold), glycoprotein 2 (3.4-fold), and 
trypsin (6.0-fold) were all significantly up-regulated in 
the duodenum (Figure 1A and B). The Northern blot 
data indicated that the up-regulation of these genes 
observed in microarray analyses of the Nkcc1-/- small 
intestine occurs primarily in the duodenum. It should be 
noted that expression of these genes in the duodenum 
appeared to be robust and did not require long exposure 
times to be detected, even in the WT samples. RT-PCR 
confirmed upregulation of Pdx1, Ins1, and Glut2 in the 
Nkcc1-/- small intestine (Figure 1C).
Morphology of the NKCC1-deficient gastrointestinal 
tract
In previous studies the stomach, intestine, liver, and pan-
creas of Nkcc1-/- mice appeared histologically normal[3], 
and no apparent differences in the morphology of the 
gastrointestinal tract was observed in the current study. 
Based on the results of the microarray analysis and 
histology, it is evident that the basic population of cells 
in the intestine of the Nkcc1-/- mice is not significantly 
altered. Expression of the Paneth cell markers matrix 
metalloproteinase 7 and lysozyme were not significantly 
changed, and neither were the expression of the major 
goblet cell markers mucin 2 and TFF3. The expression 
was alternated between WT and KO samples (dye-
flip controls) to control for the influence of fluorophore 
labeling on probe hybridization. Values are represented 
as fold­changes (ratio of fluorescence intensity values), 
with positive values indicating upregulation and negative 
values indication downregulation in KO relative to WT. 
The complete set of microarray data as well a list of 
the significantly changed genes and more detailed 
methods have been deposited in the National Center for 
Biotechnology Gene Expression Omnibus (GEO, http://
www.ncbi.nlm.nih.gov/geo/) and are available through 
GEO accession number GSE19117. The statistical 
analysis of the data has been reviewed by Dr. Mario 
Medvedovic, Director of the Division of Biostatistics and 
Bioinformatics, Department of Environmental Health, 
University of Cincinnati. 
Gene Ontology analysis
Gene Onlology analysis was performed using the 
online GOrilla program[9] (Gene Ontology enRIchment 
anaLysis and visuaLizAtion tool) (http://cbl-gorilla.
cs.technion.ac.il/). Two analysis options were used: 
(1) Single Rank List, with the entire gene set ranked 
according to P values; and (2) Two Unranked Lists, in 
which a target list of genes with a specific range of P 
values is compared against the list of all genes analyzed 
(13551 total). The Single Rank option avoids setting an 
arbitrary cutoff of P values and was useful for identifying 
GO categories that were highly enriched at the top 
end of the significance range. In the Two List analysis, 
significance and enrichment was calculated based on 
the number of genes in each GO category that appear 
in the target list and background list. Enrichment (N, B, 
n, b) is defined as: N is the total number of genes, B is 
the total number of genes associated with a specific GO 
term, n is the number of genes in the top of the user’s 
input list or in the target set when appropriate, b is the 
number of genes in the intersection; Enrichment = (b/
n)/(B/N). The program calculates statistical probabilities 
using the hypergeometric distribution[9].
Expression atlas data
RNA Seq mRNA expression data for human duodenum 
and pancreas was obtained from the European Bioin-
formatics Institute (EBI) Expression Atlas (http://
www.ebi.ac.uk/gxa/home). This data base allowed 
an evaluation of the relative expression levels of the 
various pancreatic genes that were upregulated in the 
duodenum of Nkcc1-/- mice. The data were available 
through baseline experiments, Uhlen’s lab, in which 32 
human tissues are represented.
RESULTS
Upregulation of pancreatic genes in NKCC1-null small 
intestine
Microarray analysis was performed using small intestine 
RNA from the Nkcc1-/- and WT mice. Among the top 30 
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of sucrase-isomaltase (alpha glucosidase), associated 
with terminally-differentiated enterocytes, was also not 
significantly different. Collectively, these data support 
the histological assessment that the basic structure and 
cell populations in the gut of the mutant mice are not 
significantly changed.
Immunolocalization of pancreatic enzymes in the 
duodenum
Immunofluorescence of amylase, trypsin, and elastase 
identified cytoplasmic staining of a subset of cells in 
the crypts and along the villi. Morphologically, these 
cells were clearly goblet cells. Co­immunofluorescence 
experiments using an antibody against intestinal TFF3, 
which is a goblet-cell specific marker, demonstrated 
that amylase, elastase and trypsin co-localize with Tff3 
in goblet cells (Figure 2). Although mucus is known to 
bind antibodies non-specifically, in sections containing 
only the primary or secondary antibody, the goblet cells 
excluded all background fluorescence, indicating that 
the staining for each antibody was specific.
Interestingly, all amylase-positive cells contained 
TFF3; however, not all TFF3-positive cells were amylase-
positive. This indicates that only a subset of goblet 
cells produce pancreatic-type peptidases and auxiliary 
zymogen granule proteins. Immunolocalization of amy-
lase in cells that were also stained with AB/PAS provided 
further evidence that expression was occurring in a 
subset of goblet cells, as there were AB/PAS-positive 
goblet cells that lacked amylase (Figure 3). In some 
cases, it was possible to identify an amylase or elastase-
positive cloud or cap over the lumenal border of the 
cells, and above the mucus, suggesting that these 
proteins are secreted from a separate compartment, or 
from separate granules, than TFF3-labeled mucins.
Gene Ontology analysis of differentially expressed 
genes in Nkcc1-/- intestine
The differentially expressed genes were subjected 
to Gene Ontology analysis using the online GOrilla 
program[9], and significant GO categories were identified 
(Table 3). Using the single rank option (see Methods), 
the GO categories included those dealing with digestion 
and closely related protease and triglyceride lipase 
activities, which were highly enriched in the top end 
of the significance range. Sensory perception and the 
closely related olfactory receptor/G-protein coupled 
receptor activities were also enriched using the single 
rank option; these categories included genes spanning 
a much greater significance range; this was particularly 
apparent for olfactory receptor activities. Similar 
results were obtained using the two list option and a 
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Gene symbol Description Average intensity Fold change P  value
Cpa1 Carboxypeptidase A1, pancreatic 1811 15.86   0.00001
Elane Elastase 2 2118 12.05   0.00001
Glb1l3 Galactosidase, beta 1 like 3   234 10.27 0.0001
Try4 Trypsin 4 2251   9.91   0.00001
Rnase1 Ribonuclease 1, pancreatic RNase A   592   9.28   0.00001
Cpb1 Carboxypeptidase B1   866   9.15   0.00001
Amy2a5 Amylase 2, pancreatic    691   8.75   0.00001
Try10 Trypsin 10 2306   8.33   0.00001
Ctrc Chymotrypsin C (caldecrin)   397   7.79 0.0003
Ctrb1 Chymotrypsinogen B1 3360   7.66   0.00001
Pnlip Pancreatic lipase 1938   7.24   0.00001
Prss1 Protease, serine 1 (trypsin 1) 1481   6.93   0.00001
Cel Bile salt activated lipase, pancreatic   356   6.73   0.00001
Cela3b Elastase 3B, pancreatic 1576   6.69   0.00001
Prss2 Protease, serine 2 (trypsin II)   716   6.52 0.0001
Pnliprp1 Pancreatic lipase related protein 1   574   5.83 0.0001
Muc6 Mucin 6, gastric   152   5.78 0.0053
Tff2 Trefoil factor 2   1391   5.77 0.0200
Cela1 Elastase 1, pancreatic   549   4.84 0.0002
V1rh10 Vomeronasal 1 receptor, H10   107   4.66 0.0008
Calb3 Calbindin D9K   609   4.64   0.00001  
Reg1 Lithostathine 1 (pancreatic stone protein 1) 5648   4.56 0.0008
Pdia2 Protein disulfide isomerase, pancreatic   292   4.47 0.0004
Akp3 Alkaline phosphatase 3, intestine   366   4.02   0.00001
Gp2 Glycoprotein 2 (zymogen granule membrane)   377   3.92 0.0001
Cep350 Centrosomal protein 350   141   3.92 0.0003
Bmper BMP-binding endothelial regulator   318   3.78 0.0011
Olfr846 Olfactory receptor 846   432   3.66 0.0001
Reg2 Lithostathine 2 (pancreatic stone protein 2)     253   3.58 0.0383
Ctrl Chymotrypsin like; chymotrypsin A 1431   3.49 0.0030
Table 2  Genes with the highest levels of differential expression in the Nkcc1 -null intestine
Differential expression is presented as fold-changes in Nkcc1-/- intestine relative to wild-type intestine. Average intensity (average of Cy3 and Cy5 
fluorescence intensities) is roughly indicative of relative expression levels. P values are less than or equal to the numbers shown.
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significance cutoff of P < 0.025, which analyzed the 
top 390 genes out of 13551 associated with known GO 
categories.
The most statistically significant GO categories 
included genes encoding the pancreatic enzymes that 
were discussed above, along with genes for additional 
peptidases and lipases, most of which are directed at 
digestion of food in the intestinal tract (Table 4). Most 
of these genes were upregulated; the few that were 
modestly down-regulated were peptidases with either 
no apparent role in digestion (Otud4, Dpep3, and Hpn) 
or that were expressed at very low levels for a digestive 
enzyme, such as pepsinogen 5.
The most intriguing changes involved altered exp-
ression of receptors involved in chemical sensing (Table 
5). These included some G-protein coupled receptors 
(GPCRs) that are known to be involved in chemical 
sensing in the intestinal tract, such as Gpbar1[13] and 
Ffar2[14], as well as a large number of G-protein rece-
ptors of the olfactory receptor family and several of the 
vomeronasal receptor family. As discussed below, this 
suggests that the loss of NKCC1 affects chemosensing in 
the intestinal tract, and also suggests that olfactory and 
vomeronasal receptors play a major role in this process.
DISCUSSION
The results of this study show that the loss of NKCC1 
in small intestine leads to upregulation of digestive 
enzymes, many of which are typical of the exocrine 
pancreas, and to differential expression of a large 
number of genes encoding chemosensing receptors. 
As noted in the Introduction, loss-of-function mutations 
in the SLC12A2 (NKCC1) gene lead to unexplained 
failure of intestinal function/food tolerance (http://
www.genome.gov/27551936). Although it is possible 
that impaired secretion contributes to this phenotype, 
considerable compensation for loss of NKCC1-mediated 
basolateral Cl--uptake occurs in the intestine[5,6] and 
Cystic Fibrosis patients and mice exhibit a more 
profound secretory defect than NKCC1-null mice. This 
suggests that factors other than impaired secretion 
account for the severe intestinal phenotype in humans 
with Nkcc1 mutations.
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Figure 1  Northern blot and polymerase chain reaction analysis of duodenal gene expression. A: Northern blots show upregulation of Ela, Gp2, and Try 
primarily in the duodenum of Nkcc1-/- (KO) mice relative to WT; n = 3 WT and 3 KO for each segment; B: Duodenal tissue from a separate cohort of mice confirms 
upregulation of elastase (4.7-fold, P = 0.002), glycoprotein 2 (3.5-fold, P = 0.02) and trypsin (6.0-fold, P = 0.002); n = 4 WT and 4 KO; C: Quantitative real-time 
polymerase chain reaction analysis of dx1, Ins1, and Glut2 shows increased expression of these genes in Nkcc1-/- duodenum. Expression levels were normalized 
using the L32 ribosomal subunit mRNA; n = 4 WT (black bars) and 4 KO (grey bars). aP < 0.01 vs WT, bP < 0.002 vs WT. Gp2: Glycoprotein 2; Ela: Elastase; Try: 
Trypsin; WT: Wild-type; KO: Nkcc1-/-; Pdx1: Pancreatic duodenal homeobox 1; Ins1: Insulin1; Glut2: Glucose transporter type 2.
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The most striking result of the microarray analyses, 
although perhaps of limited clinical importance (dis-
cussed below), was the increased expression of digestive 
enzymes that are normally expressed at high levels in 
the pancreas and the restriction of their expression to 
a subset of goblet cells. Because it is critical to prevent 
premature release of digestive enzymes within the 
pancreas, many digestive enzymes are produced and 
packaged as inactive forms in zymogen granules, 
which release the enzymes upon secretion into the 
duodenum. Several genes that encode proteins involved 
in zymogen granule function (Gp2, Sync, and Pdia2), 
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Figure 2  Colocalization of peptidases in goblet cells of the duodenum. DAPI (blue) identifies nuclei and TFF3 (intestinal trefoil factor, green fluorescence) 
identifies goblet cells. Elastase, amylase and trypsin are identified by red fluorescence. The merged images show colocalization of each of these proteases and TFF3. 
Staining patterns were assessed in 4 wild-type and 3 Nkcc1-/- mice. The images shown are for NKCC1-null mice. Control sections with only primary or only secondary 
antibodies do not identify goblet cells (not shown). 
Figure 3  Amylase is expressed in a subset of goblet cells. Immunofluorescence of amylase (top, red) identifies many, but not all, goblet cells that are clearly 
stained with AB/PAS (bottom). The same sections (slides) from NKCC1-null intestine was used for immunofluorescence, imaged, and then stained with AB/PAS. 
Arrows indicate the same cell in both images. AB/PAS: Alcian Blue/Periodic Acid-Schiff.
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were upregulated. Glycoprotein 2 is the most abundant 
protein on zymogen granules and is thought to regulate 
exocytosis at the apical pole of the granule[15]. Syncollin 
is found on the luminal surface of zymogen granules, 
and syncollin­deficient mice exhibit impaired exocytosis 
of granules from pancreatic acinar cells[16]. Pancreatic 
protein disulfide isomerase plays a major role in forming 
the disulfide linkages of secretory proteins and has 
been localized to zymogen granule membranes[17]. 
These expression patterns are consistent with increased 
synthesis and packaging of zymogen granule proteins in 
the Nkcc1-/- intestine.
During embryonic development, the endoderm 
gives rise to the pancreas, liver, and the epithelial 
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GO category P -value Enrichment (N, B, n , b)
Single ranked list
   GO:0008236 Serine-type peptidase activity     3.38E-14   35.6 (13551, 135, 31, 11) 
   GO:0008233  Peptidase activity   7.66E-11   12.6 (13551, 451, 31, 13)
   GO:0007586  Digestion   1.82E-10 209.8 (13551, 19, 17, 5)
   GO:0007600  Sensory perception 3.45E-8       1.67 (13551, 817, 1270, 128)
   GO:0006508  Proteolysis 4.01E-8       7.65 (13551, 743, 31, 13) 
   GO:0004984  Olfactory receptor activity 7.11E-8       1.82 (13551, 552, 1270, 94)
   GO:0004806  Triglyceride lipase activity 7.01E-7 271.0 (13551, 10, 15, 3)
   GO:0004930  GPCR activity 3.86E-5       2.41 (13551, 512, 352, 32)
Two unranked lists (target and background)
   GO:0008236  Serine-type peptidase activity 6.03E-8       4.63 (13551, 135, 390, 18) 
   GO:0007586  Digestion 5.79E-7   12.8 (13551, 19, 390, 7)
   GO:0004930  GPCR activity 1.30E-5       2.24 (13551, 512, 390, 33) 
   GO:0004984  Olfactory receptor activity 5.86E-5       2.08 (13551, 552, 390,3 3)
   GO:0004806  Triglyceride lipase activity 1.24E-4   13.9 (13551, 10, 390, 4)
   GO:0008233  Peptidase activity  2.71E-4       2.08 (13551, 451, 390, 27)
Table 3  Significantly enriched Gene Ontology categories
GO categories were identified using both the Single rank and Two unranked list options of the GOrilla Gene Ontology program[9]. N is the total number 
of genes, B is the total number of genes associated with a specific GO term, n is the number of genes in the target set, b is the number of genes in the 
intersection. Enrichment = (b/n)/(B/N). GPCR: G-protein coupled receptor; GO: Gene Ontology.
Gene symbol Description Average intensity Fold change P -value
Cpa1 Carboxypeptidase A1, pancreatic 1811 15.86   0.00001
Elane Elastase 2  2118 12.05   0.00001
Try4 Trypsin 4 2251   9.91   0.00001
Cpb1 Carboxypeptidase B1 (tissue)   866   9.15   0.00001
Try10 Trypsin 10 2306   8.33   0.00001
Ctrc Chymotrypsin C (caldecrin)   397   7.79 0.0003
Ctrb1 Chymotrypsinogen B 3360   7.66   0.00001
Pnlip Pancreatic lipase 1938   7.24   0.00001
Prss1 Protease, serine 1 (trypsin 1) 1481   6.93   0.00001
Cel Carboxyester lipase, pancreatic   356   6.73   0.00001
Cela3b Elastase 3B, pancreatic 1576   6.69   0.00001
Prss2 Trypsin Ⅱ, anionic   716   6.52 0.0001
Pnliprp1 Pancreatic lipase related protein 1   574   5.83 0.0001
Cela1 Elastase 1, pancreatic   549   4.84 0.0002
2210010C04Rik RIKEN cDNA 2210010C04 gene   125   3.89 0.0005
Ctrl Chymotrypsin like; chymotrypsin A 1431   3.49 0.0030
Klk1 Kallikrein 1   278   1.82 0.0180
Klk1b26 Kallikrein 1-related petidase b26   988   1.80 0.0030
Pnliprp2 Pancreatic lipase related protein 2   833   1.74 0.0181
Klk1b21 Kallikrein 21   386   1.66 0.0036
Cyp7b1 Cytochrome P450 7B1   100   1.53 0.0229
Prcp Prolyl carboxypeptidase (angiotensinase C)   566   1.51 0.0047
Amz1 Archaelysin family metallopeptidase 1   887   1.35 0.0121
Otud4 OTU domain containing 4   524  -1.34 0.0221
Pga5 Pepsinogen 5, group Ⅰ   168  -1.42 0.0198
Dpep3 Dipeptidase 3   301  -1.48 0.0197
Hpn Serine protease hepsin   206  -1.99 0.0211
Table 4  Digestive enzymes and peptidases altered in small intestine of Nkcc1 -/- mice
Differential expression is presented as fold-changes in Nkcc1-/- intestine relative to wild-type intestine. Average intensity (average of Cy3 and Cy5 
fluorescence intensities) is roughly indicative of relative expression levels. P values are less than or equal to the numbers shown.
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lining of the gastrointestinal tract. This requires the 
expression of various transcription factors, as well as 
interactions between the epithelium and surrounding 
mesenchyme[18,19]. It has become clear that the relative 
plasticity of the pancreas, liver, and intestine is high, 
and that certain populations of cells within these organs 
can undergo transdifferentiation. Although this initially 
seemed to be an interesting possibility, it is unlikely that 
transdifferentiation is occurring in the Nkcc1-/- small 
intestine. Several transcription factors, including Pdx1 
and pancreas transcription factor 1 (Ptf1a) have been 
shown to mediate plasticity between the pancreas and 
small intestine. Expression of Pdx1 is a key regulatory 
step in the development of both the pancreas and the 
duodenum[20], and inactivation of Ptf1a drives pancreatic 
precursor cells toward intestinal cell fates[21]. Although 
expression of pancreatic genes was upregulated, Pdx1 
was only modestly increased and expression of Ptf1a 
was not changed (data not shown). Furthermore, 
when we examined relative expression levels of the 
pancreatic enzymes in human pancreas and duodenum 
that are available through the EBI Expression Atlas (see 
methods) it was clear that the pancreatic enzymes are 
expressed at several orders of magnitude higher levels 
in pancreas than in duodenum. Thus, the apparently 
robust expression of pancreatic enzymes in the Nkcc1-/- 
intestine is likely to be far below the levels of expression 
occurring in the pancreas. Similarly, although insulin 
(Ins1) was mildly induced in Nkcc1-/- intestine, the EBI 
expression Atlas data indicates that insulin expression in 
human pancreas is far greater than that in duodenum 
(relative transcript levels 551 in pancreas vs 0.3 in 
duodenum). Although we obtained an antibody against 
human insulin, which readily and specifically identified 
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Gene symbol Description Average intensity Fold change P -value
V1rh10 Vomeronasal 1 receptor, H10   107  4.66 0.0008
Olfr846 Olfactory receptor 846   432  3.66 0.0001
Olfr491 Olfactory receptor 491     79  3.18 0.0051
Olfr419 Olfactory receptor 419   477  3.12 0.0004
Olfr827 Olfactory receptor 827   122  2.65 0.0001
Olfr992 Olfactory receptor 992   300  2.53 0.0005
Olfr506 Olfactory receptor 506   143  2.48 0.0049
Olfr812 Olfactory receptor 812     53  2.37 0.0048
Gpr63 G protein-coupled receptor 63     42  2.08 0.0023
Olfr1080 Olfactory receptor 1080     66  1.90 0.0107
V1rh1 Vomeronasal 1 receptor, H2     60  1.88 0.0071
Olfr344 Olfactory receptor 344     50  1.87 0.0057
Olfr1340 Olfactory receptor 1340     79  1.83 0.0123
Olfr378 Olfactory receptor 378     67  1.81 0.0072
Olfr643 Olfactory receptor 643     77  1.72 0.0080
Olfr1000 Olfactory receptor 996   475  1.72 0.0127
Olfr1134 Olfactory receptor 1134   139  1.71 0.0101
Olfr906 Olfactory receptor 906   134  1.68 0.0038
Olfr736 Olfactory receptor 736     92  1.67 0.0166
Olfr433 Olfactory receptor 433   189  1.65 0.0039
Olfr78 Olfactory receptor 78   125  1.62 0.0087
Olfr90 Olfactory receptor 90   106  1.56 0.0235
Prokr1 Prokineticin receptor 1   196  1.56 0.0096
Olfr1494 Olfactory receptor 1494   457  1.54 0.0180
Olfr1462 Olfactory receptor 1462   260  1.52 0.0183
Olfr444 Olfactory receptor 444   252  1.52 0.0154
Nmur1 Neuromedin U receptor 1   196  1.51 0.0177
Olfr1366 Olfactory receptor 1366     89  1.50 0.0207
Olfr804 Olfactory receptor 804   404  1.48 0.0175
Gpbar1 G protein-coupled bile acid receptor 1   129  1.47 0.0216
Gprc5a G protein-coupled receptor, C5A   936  1.46 0.0142
Olfr740 Olfactory receptor 739   172  1.43 0.0164
Olfr1156 Olfactory receptor 152   156  1.43 0.0211
Rxfp4 Relaxin family peptide receptor 4   397  1.37 0.0132
Igf2r Insulin-like growth factor 2 receptor 1089 -1.39 0.0158
Olfr641 Olfactory receptor 641   652 -1.39 0.0211
Olfr48 Olfactory receptor 140     99 -1.48 0.0143
Vmn1r210 Vomeronasal 1 receptor 210   192 -1.54 0.0127
Grm2 Glutamate receptor, metabotropic 2   179 -1.63 0.0028
Vmn1r5 Vomeronasal 1 receptor 5   124 -1.64 0.0071
Ffar2 Free fatty acid receptor 2   203 -1.85 0.0092
Table 5  G-protein coupled, olfactory, and vomeronasal receptors
Differential expression is presented as fold-changes in Nkcc1-/- intestine relative to wild-type intestine. Average intensity (average of Cy3 and Cy5 
fluorescence intensities) is roughly indicative of relative expression levels. P values are less than or equal to the numbers shown.
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pancreatic islet cells in the mouse (data not shown), 
we were unable to detect insulin in Nkcc1-/- intestine, 
consistent with exceedingly low levels of expression.
The reason for the increased expression of pan-
creatic enzymes in goblet cells is unclear. Histological 
analyses gave no evidence for an increase in goblet 
cells in Nkcc1-/- intestine, and the expression levels of 
Tff3 (intestinal trefoil factor) and Muc2 (mucin 2), which 
are expressed at very high levels in goblet cells, were 
not significantly changed. However, NKCC1 has been 
shown to be expressed at high levels on basolateral 
membranes of goblet cells[1], and there is evidence 
that it affects mucous secretion[22]. Thus, it is possible 
that the absence of NKCC1 specifically in goblet cells 
has a direct effect on the expression of pancreatic enzy-
mes. Whether this is due to subtle effects of NKCC1-
deficiency on the differentiation of goblet cells is unclear.
Despite the changes in mRNA expression patterns 
between the WT and Nkcc1-/- intestine, previous 
studies of two different NKCC1 knockouts revealed 
no significant histological changes between the two 
genotypes in the adult intestine[3,4]. Furthermore, 
detailed morphometric analyses of the intestinal tracts 
of 8-wk-old WT and Nkcc1-/- mice, the same age as used 
in the current study, revealed no significant differences 
in cell structure[3]. We cannot, of course, rule out subtle 
changes in cell differentiation resulting from changes 
during early development or during regular turnover 
of the epithelium. However, the normal epithelial cell 
structure and relatively modest changes in expression 
of two of the major transcription factors involved in 
development of the pancreas and intestine, argue 
against defects in development and/or epithelial cell 
differentiation as the basis of the observed expression 
changes. Also, as discussed below, NKCC1 serves a 
direct role in the process of chemical sensing in olfactory 
neurons, suggesting that the changes in expression 
of chemosensing receptors is a direct response to 
the absence NKCC1 rather than being secondary to 
developmental defects. 
Although less dramatic than the changes in pancre-
atic genes, the significant changes in expression of 
a large number of G-protein coupled chemosensing 
receptors suggest that the loss of NKCC1 may cause 
major impairments in the sensing of nutrients and other 
constituents of the intestinal contents. It is clear from 
many studies that GPCRs play a major role in intestinal 
chemosensing[23]. In fact, some of the GPCRs identified as 
differentially expressed in our microarray analyses have 
been shown to play important roles in chemosensing 
in the gut. Gpbar1 (1.47-fold increase) is expressed in 
enteroendocrine L-cells, where it senses bile acids and 
transduces a signal that leads to secretion of glucagon-
like peptide 1 (GLP-1) and peptide tyrosine-tyrosine, 
thereby regulating glucose homeostasis[13,24]. Ffar2 
(-1.85-fold decrease) is expressed in enteroendocrine 
cells and serves as a sensor of short-chain fatty acids[14]. 
Gpr63 (2.1-fold increase), which was expressed at 
relatively low levels, has been identified as a receptor for 
several lipids, including N-Arachidonylethanolamine[25] 
and both sphingosine 1-phosphate and dioleoylp-
hasphatidic acid[26]. Grm2 (-1.63-fold decrease) is one of 
the metabotropic glutamate receptors that is involved in 
nutrient sensing through taste receptors[27]. Several of 
the differentially expressed GPCRs serve as receptors for 
peptide hormones that affect gut function. These include 
Rxfp4 (1.37-fold increase), which is the receptor for the 
orexigenic (appetite-stimulating) insulin-like peptide 5[28], 
and Nmur1 (1.51-fold increase), which is a receptor for 
neuromedin U and functions in glucose and appetite 
homeostasis[29].
The GPCRs that are known to play major roles in 
chemical sensing include taste receptors, olfactory 
receptors, and volmeronasal receptors. Taste receptors 
are known to function in the intestinal tract and to 
play major roles in nutrient sensing and subsequent 
signaling events[27,30-32]. There is less information about 
the role of olfactory receptors in chemosensing in the 
intestinal tract, but recent evidence indicates that olfa-
ctory receptors are expressed on colonic epithelial 
tissues, where they may detect bacterial metabolites in 
the luminal contents[33]. In addition, specific olfactory 
receptors have been shown to be differentially expressed 
in the duodenum of obesity-prone rats fed a high-fat 
diet[34]. The authors speculated that these receptors 
may be involved in sensing and responding to dietary 
fat. Specific olfactory receptors have also been identified 
in human enterochromaffin cells and when stimulated 
can lead to the release of serotonin[35,36]. Vomeronasal 
receptors also function in chemosensing[37], but as 
far as we are aware there is no previous evidence for 
their expression and function in the intestinal tract. 
Nevertheless, V1rh10 was the most highly upregulated 
gene among the G-protein coupled receptors (4.66-fold), 
indicating that it’s expression is responsive to the loss of 
NKCC1.
Previous studies have shown that NKCC1 plays an 
important role in signaling through olfactory receptors. 
Odorant-induced Cl- currents, which are required 
for signaling, were reduced in olfactory neurons of 
Nkcc1-/- mice[38], indicating that NKCC1 is an important 
mechanism for Cl--uptake in olfactory neurons. 
However, later studies provided strong evidence for 
additional Cl--loading mechanisms that can provide 
some compensation for the loss of NKCC1[39,40], and 
physiological studies indicated that WT and Nkcc1-/- mice 
have similar sensitivities to several specific odorants[41]. 
In more recent studies, however, loss of NKCC1 
caused defects in the sensitivity to a complex mixture 
of odorants, and RNA Seq analysis of WT and Nkcc1-/- 
olfactory epithelium revealed significant differential 
expression changes involving a large number of olfactory 
receptors[42]. Thus, loss of NKCC1 leads to differential 
expression changes involving chemosensing receptors 
in both the olfactory epithelium[42] and in the small 
intestine, as indicated in the current study.
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In summary, the microarray analysis of Nkcc1-/- 
small intestine indicates that the loss of NKCC1 leads 
both to increased expression of pancreatic enzymes in 
a subset of goblet cells and to differential expression 
of chemosensing GPCRs, including a large number of 
olfactory receptors. Because a number of GPCRs with 
well-established roles in chemosensing in the intestine 
were among the receptors that were changed, it 
seems likely that the differential expression of olfactory 
receptors is also indicative of altered sensing of com-
ponents of the luminal contents. This finding raises the 
possibility that the episodic hypoglycemia and failure of 
intestinal function/food tolerance observed in human 
patients with NKCC1 (SLC12A2 gene) mutations may 
be due to chronic deficiencies in their ability to properly 
sense and respond to nutrients and other constituents of 
the intestinal lumen. Finally, it should also be noted that 
loop diuretics that inhibit NKCC1 have been associated 
with an increased incidence of intestinal dysfunction, 
including constipation[43] and indications of a poor 
outcome following ischemic colitis[44]. It is therefore 
possible that inhibition of NKCC1 by these common 
therapeutic agents could lead to intestinal dysfunction 
similar to that observed in NKCC1 genetic deficiencies. 
Whether this is due to developmental abnormalities 
involving one or more cell types in the intestinal epit-
helium and/or is a more direct response to impaired 
chemosensing is unclear. 
COMMENTS 
Background
In the intestine, the basolateral NKCC1 Na+-K+-2Cl- cotransporter is the major 
mechanism of chloride uptake in support of secretion; however, it is not 
restricted to secretory epithelia and may serve other functions as well. To gain 
insights regarding novel functions of NKCC1 in the intestine, mRNA expression 
patterns in wild-type and NKCC1-null intestine were analyzed.
Research frontiers
This study was designed to determine changes in gene expression occurring in 
the intestinal tract of mice lacking NKCC1. Analysis of those patterns provided 
evidence that NKCC1 plays an important role in chemical sensing in the 
intestinal tract, a relatively new area of investigation.
Innovations and breakthroughs
This study demonstrates for the first time that mRNA levels for a large number 
of olfactory receptors and other G-protein coupled receptors involved in 
chemical sensing in the intestinal tract are altered in response to the loss of 
NKCC1. 
Applications
The effects of NKCC1 ablation on the expression of large numbers of 
chemosensory receptors raises the possibility that the failure of intestinal 
function in response to genetic mutations in the human NKCC1 gene and side 
effects of loop diuretic treatment in the intestine could be due in part to impaired 
chemical sensing. 
Terminology
The Slc12a2 gene, encoding the NKCC1 Na+-K+-2Cl- cotransporter, was 
genetically ablated in the mouse model used in this study. The corresponding 
human gene is SLC12A2; mutations in human SLC12A2 gene have been 
shown to cause failure of intestinal function. 
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